THE INFLUENCE OF VARIOUS EXPERIMENTAL CONDITIONS ON THE EXPRESSION OF NALOXONE-INDUCED WITHDRAWAL SYMPTOMS IN MICE

被引:42
作者
ELKADI, AOS [1 ]
SHARIF, SI [1 ]
机构
[1] AL ARAB MED UNIV, FAC MED, DEPT PHARMACOL, BENGHAZI, LIBYA
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1994年 / 25卷 / 07期
关键词
DEPENDENCE; MICE; MORPHINE; NALOXONE; WITHDRAWAL SYMPTOMS;
D O I
10.1016/0306-3623(94)90181-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Physical dependence was induced in mice by repeated injections of increasing doses of morphine for either 4 or 7 days. 2. Withdrawal symptoms induced by naloxone (1 mg/kg, i.p.) given 3 hr postmorphine were more severe in mice treated for 7 than for 4 days. 3. In mice that developed a similar degree of dependence, various doses of naloxone (0.1-10 mg/kgf given 3 hr postmorphine produced withdrawal symptoms of different intensities. 4. Withdrawal jumping was maximal at naloxone (1 mg/kg) but declined with further increases in the dose of the antagonist. 5. ''Wet dog'' shakes progressively increased with increasing doses of naloxone (0.1-10 mg/kg). 6. Variation in the temporal time interval between the last dose of morphine and that of naloxone (1 mg/kg) influenced the intensity of withdrawal symptoms. 7. In male and female mice that developed a similar degree of dependence, no major differences were observed in the severity of withdrawal symptoms-induced by naloxone (1 mg/kg) given 3 hr postmorphine.
引用
收藏
页码:1505 / 1510
页数:6
相关论文
共 19 条
[1]  
BLASIG J, 1973, PSYCHOPHARMACOLOGIA, V33, P19
[2]  
CICERO TJ, 1973, J PHARMACOL EXP THER, V184, P404
[3]   MODIFICATION OF MORPHINE WITHDRAWAL BY DRUGS INTERACTING WITH HUMORAL MECHANISMS - SOME CONTRADICTIONS AND THEIR INTERPRETATION [J].
COLLIER, HOJ ;
SCHNEIDER, C ;
FRANCIS, DL .
NATURE, 1972, 237 (5352) :220-+
[4]  
DEWEY WL, 1971, J PHARMACOL EXP THER, V179, P652
[5]   NALOXONE AS A GABA ANTAGONIST - EVIDENCE FROM IONTOPHORETIC, RECEPTOR-BINDING AND CONVULSANT STUDIES [J].
DINGLEDINE, R ;
IVERSEN, LL ;
BREUKER, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 47 (01) :19-27
[6]  
FRANCIS DL, 1971, BRIT J PHARMACOL, V41, pP424
[7]   EFFECT OF NALOXONE ON CEREBELLAR CGMP CONTENT - POSSIBLE GABA-ANTAGONISTIC ACTION [J].
GUMULKA, SW ;
DINNENDAHL, V ;
SCHONHOFER, PS .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1979, 306 (02) :169-172
[8]  
HUIDOBRO F, 1963, ARCH INT PHARMACOD T, V144, P196
[9]  
JASINSKI DR, 1967, J PHARMACOL EXP THER, V157, P420
[10]  
MARSHALL I, 1971, J PHARMACOL EXP THER, V179, P634